273 related articles for article (PubMed ID: 11224753)
1. A clinical comparison of the safety and efficacy of MultiHance (gadobenate dimeglumine) and Omniscan (Gadodiamide) in magnetic resonance imaging in patients with central nervous system pathology.
Runge VM; Armstrong MR; Barr RG; Berger BL; Czervionke LF; Gonzalez CF; Halford HH; Kanal E; Kuhn MJ; Levin JM; Low RN; Tanenbaum LN; Wang AM; Wong W; Yuh WT; Zoarski GH
Invest Radiol; 2001 Feb; 36(2):65-71. PubMed ID: 11224753
[TBL] [Abstract][Full Text] [Related]
2. Double-blind, efficacy evaluation of gadobenate dimeglumine, a gadolinium chelate with enhanced relaxivity, in malignant lesions of the brain.
Runge VM; Parker JR; Donovan M
Invest Radiol; 2002 May; 37(5):269-80. PubMed ID: 11979153
[TBL] [Abstract][Full Text] [Related]
3. Detection of intracranial metastases: a multicenter, intrapatient comparison of gadobenate dimeglumine-enhanced MRI with routinely used contrast agents at equal dosage.
Colosimo C; Ruscalleda J; Korves M; La Ferla R; Wool C; Pianezzola P; Kirchin MA
Invest Radiol; 2001 Feb; 36(2):72-81. PubMed ID: 11224754
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced MR imaging of brain lesions: a large-scale intraindividual crossover comparison of gadobenate dimeglumine versus gadodiamide.
Rowley HA; Scialfa G; Gao PY; Maldjian JA; Hassell D; Kuhn MJ; Wippold FJ; Gallucci M; Bowen BC; Schmalfuss IM; Ruscalleda J; Bastianello S; Colosimo C
AJNR Am J Neuroradiol; 2008 Oct; 29(9):1684-91. PubMed ID: 18599575
[TBL] [Abstract][Full Text] [Related]
5. Dose Finding Study of Gadopiclenol, a New Macrocyclic Contrast Agent, in MRI of Central Nervous System.
Bendszus M; Roberts D; Kolumban B; Meza JA; Bereczki D; San-Juan D; Liu BP; Anzalone N; Maravilla K
Invest Radiol; 2020 Mar; 55(3):129-137. PubMed ID: 31917762
[TBL] [Abstract][Full Text] [Related]
6. Gadobenate dimeglumine-enhanced MRI of the breast: analysis of dose response and comparison with gadopentetate dimeglumine.
Knopp MV; Bourne MW; Sardanelli F; Wasser MN; Bonomo L; Boetes C; Müller-Schimpfle M; Hall-Craggs MA; Hamm B; Orlacchio A; Bartolozzi C; Kessler M; Fischer U; Schneider G; Oudkerk M; Teh WL; Gehl HB; Salerio I; Pirovano G; La Noce A; Kirchin MA; Spinazzi A
AJR Am J Roentgenol; 2003 Sep; 181(3):663-76. PubMed ID: 12933457
[TBL] [Abstract][Full Text] [Related]
7. Signal intensity change on unenhanced T1-weighted images in dentate nucleus following gadobenate dimeglumine in patients with and without previous multiple administrations of gadodiamide.
Ramalho J; Semelka RC; AlObaidy M; Ramalho M; Nunes RH; Castillo M
Eur Radiol; 2016 Nov; 26(11):4080-4088. PubMed ID: 26911888
[TBL] [Abstract][Full Text] [Related]
8. Multicenter, intraindividual comparison of single-dose gadobenate dimeglumine and double-dose gadopentetate dimeglumine for MR angiography of the supra-aortic arteries (the Supra-Aortic VALUE study).
Li Y; Li X; Li D; Lu J; Xing X; Yan F; Li Y; Wang X; Iezzi R; De Cobelli F
AJNR Am J Neuroradiol; 2013 Apr; 34(4):847-54. PubMed ID: 23042922
[TBL] [Abstract][Full Text] [Related]
9. Primary and secondary brain tumors at MR imaging: bicentric intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine.
Knopp MV; Runge VM; Essig M; Hartman M; Jansen O; Kirchin MA; Moeller A; Seeberg AH; Lodemann KP
Radiology; 2004 Jan; 230(1):55-64. PubMed ID: 14695387
[TBL] [Abstract][Full Text] [Related]
10. Multicenter, double-blind, randomized, intra-individual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine in MRI of brain tumors at 3 tesla.
Rumboldt Z; Rowley HA; Steinberg F; Maldjian JA; Ruscalleda J; Gustafsson L; Bastianello S
J Magn Reson Imaging; 2009 Apr; 29(4):760-7. PubMed ID: 19306364
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Low-Dose Higher-Relaxivity and Standard-Dose Lower-Relaxivity Contrast Media for Delayed-Enhancement MRI: A Blinded Randomized Crossover Study.
Cheong BY; Duran C; Preventza OA; Muthupillai R
AJR Am J Roentgenol; 2015 Sep; 205(3):533-9. PubMed ID: 26295638
[TBL] [Abstract][Full Text] [Related]
12. Comparison of gadobenate dimeglumine and gadodiamide in the evaluation of spinal vascular anatomy with MR angiography.
Spampinato MV; Nguyen SA; Rumboldt Z
AJNR Am J Neuroradiol; 2010 Jun; 31(6):1151-6. PubMed ID: 20053811
[TBL] [Abstract][Full Text] [Related]
13. Gadobenate dimeglumine-enhanced MR angiography of the abdominal aorta and renal arteries.
Kroencke TJ; Wasser MN; Pattynama PM; Barentsz JO; Grabbe E; Marchal G; Knopp MV; Schneider G; Bonomo L; Pennell DJ; del Maschio A; Hentrich HR; Daprà M; Kirchin MA; Spinazzi A; Taupitz M; Hamm B
AJR Am J Roentgenol; 2002 Dec; 179(6):1573-82. PubMed ID: 12438058
[TBL] [Abstract][Full Text] [Related]
14. Neurotolerability of contrast agents in rats with brain ischemia induced by transient middle cerebral artery occlusion: EEG evaluation.
Frigeni V; Miragoli L; Grotti A; Lorusso V
Invest Radiol; 2001 Jan; 36(1):1-8. PubMed ID: 11176255
[TBL] [Abstract][Full Text] [Related]
15. Acute Adverse Events Following Gadolinium-based Contrast Agent Administration: A Single-Center Retrospective Study of 281 945 Injections.
McDonald JS; Hunt CH; Kolbe AB; Schmitz JJ; Hartman RP; Maddox DE; Kallmes DF; McDonald RJ
Radiology; 2019 Sep; 292(3):620-627. PubMed ID: 31264948
[TBL] [Abstract][Full Text] [Related]
16. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
Bauner KU; Reiser MF; Huber AM
Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
[TBL] [Abstract][Full Text] [Related]
17. Low-dose gadobenate dimeglumine versus standard dose gadopentetate dimeglumine for contrast-enhanced magnetic resonance imaging of the liver: an intra-individual crossover comparison.
Schneider G; Maas R; Schultze Kool L; Rummeny E; Gehl HB; Lodemann KP; Kirchin MA
Invest Radiol; 2003 Feb; 38(2):85-94. PubMed ID: 12544071
[TBL] [Abstract][Full Text] [Related]
18. Comparison of gadobenate dimeglumine (Gd-BOPTA) with gadopentetate dimeglumine (Gd-DTPA) for enhanced MR imaging of brain and spine tumours in children.
Colosimo C; Demaerel P; Tortori-Donati P; Christophe C; Van Buchem M; Högström B; Pirovano G; Shen N; Kirchin MA; Spinazzi A
Pediatr Radiol; 2005 May; 35(5):501-10. PubMed ID: 15678342
[TBL] [Abstract][Full Text] [Related]
19. Safety and Diagnostic Efficacy of Gadobenate Dimeglumine in MRI of the Brain and Spine of Neonates and Infants.
Enterline DS; Martin KW; Parmar HA; Triulzi FM; Colosimo C
AJNR Am J Neuroradiol; 2019 Dec; 40(12):2001-2009. PubMed ID: 31727753
[TBL] [Abstract][Full Text] [Related]
20. Contrast-enhanced MR angiography: does a higher relaxivity MR contrast agent permit a reduction of the dose administered for routine vascular imaging applications?
Xing X; Zeng X; Li X; Zhao Q; Kirchin MA; Pirovano G; Wang X; Li Y; Iezzi R; De Cobelli F
Radiol Med; 2015 Feb; 120(2):239-50. PubMed ID: 25183340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
